Welcome to our dedicated page for PANTERA SILVER news (Ticker: PNTRF), a resource for investors and traders seeking the latest updates and insights on PANTERA SILVER stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PANTERA SILVER's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PANTERA SILVER's position in the market.
Pantera Silver (TSXV: PNTR, OTC: PNTRF) reported the exercise of 11,304,333 share purchase warrants at an exercise price of $0.20 per share, generating aggregate gross proceeds of $2,260,866.60. The warrants originated from private placements completed in July 2024 and were exercised before their expiry dates in July 2026.
Following these exercises, Pantera Silver now has 78,938,222 common shares issued and outstanding. According to the company, proceeds will fund exploration at the Rakanco Silver Project in Bolivia, potential mineral concession acquisitions and strategic staking, and general working capital.